These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11845294)

  • 21. Cystic fibrosis: basic science.
    McAuley DF; Elborn JS
    Paediatr Respir Rev; 2000 Jun; 1(2):93-100. PubMed ID: 12531100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Finally, mice with CF lung disease.
    Frizzell RA; Pilewski JM
    Nat Med; 2004 May; 10(5):452-4. PubMed ID: 15122239
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cystic fibrosis modifying genes].
    Knauer N; Ratjen F; Grasemann H
    Pneumologie; 2005 Jun; 59(6):395-404. PubMed ID: 15991075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of snare proteins in CFTR and ENaC trafficking.
    Peters KW; Qi J; Johnson JP; Watkins SC; Frizzell RA
    Pflugers Arch; 2001; 443 Suppl 1():S65-9. PubMed ID: 11845306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunopathophysiologic mechanisms of cystic fibrosis lung disease.
    Soferman R
    Isr Med Assoc J; 2006 Jan; 8(1):44-8. PubMed ID: 16450752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice.
    Mall M; Grubb BR; Harkema JR; O'Neal WK; Boucher RC
    Nat Med; 2004 May; 10(5):487-93. PubMed ID: 15077107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Relation between gene mutations and pancreatic exocrine function in patients with cystic fibrosis].
    Radivojević D; Guć-Sćekić M; Djurisić M; Lalić T; Minić P; Kanavakis E
    Srp Arh Celok Lek; 2001; 129 Suppl 1():6-9. PubMed ID: 15637983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cystic fibrosis and other channelopathies].
    Edelman A; Saussereau E
    Arch Pediatr; 2012 May; 19 Suppl 1():S13-6. PubMed ID: 22682482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [From the laboratory to the clinic: CFTR and the therapeutic options for cystic fibrosis].
    Mayol J; Alvarez de Arcaya Vicente A; Arbeo Escolar AM; Peña Soria MJ; Alvarez Fernández-Represa J
    An Med Interna; 2000 Feb; 17(2):92-8. PubMed ID: 10829466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ENaCbeta and gamma genes as modifier genes in cystic fibrosis.
    Viel M; Leroy C; Hubert D; Fajac I; Bienvenu T
    J Cyst Fibros; 2008 Jan; 7(1):23-9. PubMed ID: 17560176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genotype-phenotype correlation in cystic fibrosis: the role of modifier genes.
    Salvatore F; Scudiero O; Castaldo G
    Am J Med Genet; 2002 Jul; 111(1):88-95. PubMed ID: 12124743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modifier genes in cystic fibrosis lung disease.
    Merlo CA; Boyle MP
    J Lab Clin Med; 2003 Apr; 141(4):237-41. PubMed ID: 12677168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HCO3- transport in relation to mucus secretion from submucosal glands.
    Joo NS; Krouse ME; Wu JV; Saenz Y; Jayaraman S; Verkman AS; Wine JJ
    JOP; 2001 Jul; 2(4 Suppl):280-4. PubMed ID: 11875272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defective formation of PKA/CnA-dependent annexin 2-S100A10/CFTR complex in DeltaF508 cystic fibrosis cells.
    Borthwick LA; Riemen C; Goddard C; Colledge WH; Mehta A; Gerke V; Muimo R
    Cell Signal; 2008 Jun; 20(6):1073-83. PubMed ID: 18346874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New concepts of pathophysiology and therapy in cystic fibrosis].
    Hirche TO; Loitsch S; Smaczny C; Wagner TO
    Pneumologie; 2005 Nov; 59(11):811-8. PubMed ID: 16385442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of the amiloride-sensitive epithelial Na+ channel in the pathogenesis and as a therapeutic target for cystic fibrosis lung disease.
    Mall MA
    Exp Physiol; 2009 Feb; 94(2):171-4. PubMed ID: 19060118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cystic fibrosis transmembrane conductance regulator (CFTR) gene: mutations and clinical phenotypes].
    Schwartz M
    Ugeskr Laeger; 2003 Feb; 165(9):912-6. PubMed ID: 12661515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological therapy for cystic fibrosis: from bench to bedside.
    Becq F; Mall MA; Sheppard DN; Conese M; Zegarra-Moran O
    J Cyst Fibros; 2011 Jun; 10 Suppl 2():S129-45. PubMed ID: 21658632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Is molecular biology useful to the practitioner?].
    Waeber G; Haefliger JA
    Schweiz Med Wochenschr; 1997 Mar; 127(13):554-60. PubMed ID: 9190668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cystic fibrosis transmembrane regulator (CFTR) in the kidney.
    Morales MM; Falkenstein D; Lopes AG
    An Acad Bras Cienc; 2000 Sep; 72(3):399-406. PubMed ID: 11028104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.